Professor of Respiratory Medicine
Professor Pavord has a particular interest in asthma, chronic pulmonary disease and chronic cough. He is an internationally renowned researcher in these areas and has played a lead role in developing three of the most promising emerging treatments. He has published 350 scientific papers, including three of the 20 most cited papers in the field in the last 10 years. He has an H-index of 74. His main contribution has been to develop new methods to assess and treat airway inflammation and airway diseases.
He has been joint Chief Medical Advisor to Asthma UK since May 2008 and joint Editor of Thorax since 2010.
in 2016 Professor Pavord was awarded The ERS Gold Medal in Asthma in recognition of his outstanding contribution in the field of asthma research.
Defining severe obstructive lung disease in the biologic era: an endotype-based approach.
Martin RJ. et al, (2019), Eur Respir J
COPD exacerbation phenotypes: The next frontier.
Moran A. and Pavord ID., (2019), Respirology (Carlton, Vic.)
Resistance to apoptosis underpins corticosteroid-insensitivity of group 2 innate lymphoid cells.
Luo J. et al, (2019), J Allergy Clin Immunol
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma With Self-reported Chronic Rhinosinusitis.
Maspero JF. et al, (2019), J Allergy Clin Immunol Pract
Reply to: Inhaled Corticosteroids and Adult Asthma.
Beasley R. et al, (2019), Am J Respir Crit Care Med